✦ LIBER ✦

Combination of vemurafenib and cobimetinib in patients with advanced BRAFV600-mutated melanoma: a phase 1b study

✍ Scribed by Ribas, Antoni; Gonzalez, Rene; Pavlick, Anna; Hamid, Omid; Gajewski, Thomas F; Daud, Adil; Flaherty, Lawrence; Logan, Theodore; Chmielowski, Bartosz; Lewis, Karl; Kee, Damien; Boasberg, Peter; Yin, Ming; Chan, Iris; Musib, Luna; Choong, Nicholas; Puzanov, Igor; McArthur, Grant A

Book ID: 125825681
Publisher: The Lancet
Year: 2014
Tongue: English
Weight: 466 KB
Volume: 15
Category: Article
ISSN: 1470-2045
DOI: 10.1016/S1470-2045(14)70301-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Vemurafenib in patients with BRAFV600 mu

Vemurafenib in patients with BRAFV600 mutated metastatic melanoma: an open-label, multicentre, safety study

✍ Larkin, James; Del Vecchio, Michele; Ascierto, Paolo A; Krajsova, Ivana; Schacht 📂 Article 📅 2014 🏛 The Lancet 🌐 English ⚖ 297 KB

Biomarker analysis of on-treatment and a

Biomarker analysis of on-treatment and at progression biopsies from BRIM7 - a phase 1B trial of combined vemurafenib and cobimetinib treatment in BRAF V600 mutated melanoma

✍ Yan, Yibing; McArthur, Grant; Hamid, Omid; Puzanov, Igor; Gonzalez, Rene; Gajews 📂 Article 📅 2014 🏛 BioMed Central 🌐 English ⚖ 88 KB

Vemurafenib in patients with BRAFV600 mu

Vemurafenib in patients with BRAFV600 mutation-positive melanoma with symptomatic brain metastases: Final results of an open-label pilot study

✍ Dummer, Reinhard; Goldinger, Simone M.; Turtschi, Christian P.; Eggmann, Nina B. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 702 KB

Updated results and correlative FDG-PET

Updated results and correlative FDG-PET analysis of a phase IB study of vemurafenib and cobimetinib (MEK inhibitor [GDC-0973]), in advancedBRAFV600- mutated melanoma (BRIM7)

✍ Puzanov, Igor; McArthur, Grant; Gonzalez, Rene; Pavlick, Anna; Hamid, Omid; Gaje 📂 Article 📅 2014 🏛 BioMed Central 🌐 English ⚖ 92 KB

BRIM-1, -2 and -3 trials: improved survi

BRIM-1, -2 and -3 trials: improved survival with vemurafenib in metastatic melanoma patients with a BRAF V600E mutation

✍ Young, Kate; Minchom, Anna; Larkin, James 📂 Article 📅 2012 🏛 Future Medicine 🌐 English ⚖ 702 KB

Interferon in combination with vinblasti

Interferon in combination with vinblastine in advanced malignant melanoma. A phase I–II study

✍ Stein Gundersen; A. Flokkmann 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 288 KB 👁 2 views

Nineteen patients with advanced malignant melanoma were treated with a combination of recombinant alfa-interferon (a-IFN) and vinblastine (VBL). The a-IFN was administered subcutaneously daily at an initial dose of 3 X lo6 IU escalating to a maximal dose of 9 X lo6 U daily for the first 10 weeks fol